These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The serum bactericidal and opsonizing defect in sickle cell anaemia: restoration of activity by control serum. Luo NP; Rowland HA Trans R Soc Trop Med Hyg; 1986; 80(2):317-22. PubMed ID: 3538524 [TBL] [Abstract][Full Text] [Related]
23. Heat labile opsonin system to pneumococcus. Shin HS; Smith MR; Winkelstein J; Nicholson A Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689 [TBL] [Abstract][Full Text] [Related]
24. Type-specific antibodies in children with sickle cell anemia given polyvalent pneumococcal vaccine. Kaplan J; Frost H; Sarnaik S; Schiffman G J Pediatr; 1982 Mar; 100(3):404-6. PubMed ID: 7062172 [No Abstract] [Full Text] [Related]
25. Opsonic activity in human serum deficient in C2. Johnson FR; Agnello V; Williams RC J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482 [No Abstract] [Full Text] [Related]
26. Opsonization of Salmonella enteritidis lipopolysaccharide in sickle cell disease. Field RJ; Overturf GD; Strunk R Pediatr Res; 1981 Feb; 15(2):107-11. PubMed ID: 7019833 [No Abstract] [Full Text] [Related]
27. Immunodeficiency in sickle-cell anemia. Ringelhann B N Engl J Med; 1973 Aug; 289(6):326-7. PubMed ID: 4718046 [No Abstract] [Full Text] [Related]
28. Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits. Reed WP; Jaffee P; Albright EL; Williams RC Infect Immun; 1980 Sep; 29(3):1021-7. PubMed ID: 7429626 [TBL] [Abstract][Full Text] [Related]
29. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens. Giebink GS; Grebner JV; Kim Y; Quie PG Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937 [TBL] [Abstract][Full Text] [Related]
32. Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections. Landesman SH; Rao SP; Ahonkhai VI Am J Pediatr Hematol Oncol; 1982; 4(4):407-18. PubMed ID: 7168489 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia. Chintu C; Gupta K; Osborne C; Masona JM Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155 [No Abstract] [Full Text] [Related]
34. Opsonizing antibodies against pneumococci detected by enhanced NBT. Reduction of phagocytizing granulocytes. Urban T; Jarstrand C; Tunevall G Infection; 1982; 10(5):271-6. PubMed ID: 7174111 [TBL] [Abstract][Full Text] [Related]
35. Increased susceptibility to infection in sickle cell disease: review of its occurrence and possible causes. Johnston RB South Med J; 1974 Nov; 67(11):1342-8. PubMed ID: 4610771 [No Abstract] [Full Text] [Related]
36. Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia. Buchanan GR; Schiffman G J Pediatr; 1980 Feb; 96(2):264-6. PubMed ID: 7351592 [No Abstract] [Full Text] [Related]
37. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia. Kaplan J; Sarnaik S; Schiffman G Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518 [TBL] [Abstract][Full Text] [Related]
38. Serum complement activity in normal individuals and patients with sickle cell hemoglobin abnormalities. Francis WG; Womack CR Am J Med Technol; 1967; 33(2):77-86. PubMed ID: 6041787 [No Abstract] [Full Text] [Related]
40. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. Vernacchio L; Neufeld EJ; MacDonald K; Kurth S; Murakami S; Hohne C; King M; Molrine D J Pediatr; 1998 Aug; 133(2):275-8. PubMed ID: 9709721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]